INT268896

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.23
First Reported 2007
Last Reported 2007
Negated 0
Speculated 0
Reported most in Body
Documents 1
Total Number 2
Disease Relevance 0
Pain Relevance 0

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

enzyme regulator activity (Sln)
Sln (Mus musculus)
Pain Link Frequency Relevance Heat
Parenteral administration 12 5.00 Very Low Very Low Very Low
Bioavailability 12 5.00 Very Low Very Low Very Low
cva 4 5.00 Very Low Very Low Very Low
Bile 2 5.00 Very Low Very Low Very Low
tolerance 2 5.00 Very Low Very Low Very Low
transdermal 2 5.00 Very Low Very Low Very Low
Pain 2 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Toxicity 16 5.00 Very Low Very Low Very Low
Cancer 4 5.00 Very Low Very Low Very Low
Cv General 3 Under Development 4 5.00 Very Low Very Low Very Low
Pain 2 5.00 Very Low Very Low Very Low
Influenza Virus Infection 2 5.00 Very Low Very Low Very Low
Death 2 5.00 Very Low Very Low Very Low
Acquired Immune Deficiency Syndrome Or Hiv Infection 2 5.00 Very Low Very Low Very Low
Volume Depletion And Dehydration 2 5.00 Very Low Very Low Very Low

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
An acidic aqueous phase is required in order to adjust the zeta potential to induce lipid coacervation, which leads to formation of SLN.
SLN Binding (formation) of
1) Confidence 0.23 Published 2007 Journal International Journal of Nanomedicine Section Body Doc Link PMC2676808 Disease Relevance 0 Pain Relevance 0
The obtained nanoemulsion recrystallizes upon cooling down to room temperature forming SLN (Carsten et al 2004).
SLN Binding (cooling) of
2) Confidence 0.20 Published 2007 Journal International Journal of Nanomedicine Section Body Doc Link PMC2676808 Disease Relevance 0 Pain Relevance 0

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox